Congenital hyperinsulinism: the significance of visual evaluation of positron emission tomography and the role of the surgeon in determining the limits of pancreatic resection

Abstract

BACKGROUND: Congenital hyperinsulinism is a complex and multifaceted disease due to genetic disorders, some of which remain unknown.

AIM: This investigation shows the value of visual assessment and not just the definition of indices (standardized accumulation index and pancreatic index) when performing PET/CT to determine the surgical correction method of congenital hyperinsulinism.

MATERIALS AND METHODS: In 2017, Almazov NMRC implemented modern diagnostic capabilities for diagnosing pancreatic lesions: positron emission tomography with 18F-DOPA and intraoperative express biopsy of the pancreas.

RESULTS: From 2017 to October 2021, 48 children were operated on with congenital hyperinsulinism, including 30 with focal forms, in the Department of Pediatric Surgery at Almazov NMRC. This article shows the role of the surgeon, the importance of visual assessment, and not only the determination of indices (standardized accumulation index and pancreatic index) during positron emission tomography to determine the surgical correction method of congenital hyperinsulinism. The presented approach leads to 100% recovery in focal disease forms.

CONCLUSION: Partial pancreatectomy was performed in patients with focal forms, subtotal (95%) in atypical, and near total (98%–99%) in diffuse forms to cope with hypoglycemia due to congenital hyperinsulinism. The scope of surgical treatment for children with congenital hyperinsulinism is determined by the data of genetic examination, positron emission tomography, and intraoperative express biopsy.

Keywords

congenital hyperinsulinism / hypoglycemia / positron emission tomography / pancreathectomy / children / express biopsy

References

[1] McQuarrie I. Idiopathic spontaneously occurring hypoglycemia in infants; clinical significance of problem and treatment. Am J Dis Child. 1954;87(4):399–428. DOI: 10.1001/archpedi.1954.02050090387001

[2] McQuarrie I. Idiopathic spontaneously occurring hypoglycemia in infants; clinical significance of problem and treatment // Am J Dis Child. 1954. Vol. 87. No. 4. P. 399–428. DOI: 10.1001/archpedi.1954.02050090387001

[3] Bruining GJ. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr. 1990;2(4):758–765. DOI: 10.1097/00008480-199008000-00024

[4] Bruining G.J. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus // Curr Opin Pediatr. 1990. Vol. 2. No. 4. P. 758–765. DOI: 10.1097/00008480-199008000-00024

[5] Mathew PM, Young JM, Abu-Osba YK, et al. Persistent neonatal hyperinsulinism. Clin Pediatr(Phila). 1988;27(3):148–151. DOI: 10.1177/000992288802700307

[6] Mathew P.M., Young J.M., Abu-Osba Y.K., et al. Persistent neonatal hyperinsulinism // Clin Pediatr (Phila). 1988. Vol. 27. No. 3. P. 148–151. DOI: 10.1177/000992288802700307

[7] Roženková K, Güemes M, Shah P, Hussain K. The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia. J Clin Res Pediatr Endocrinol. 2015;7(2):86–97. DOI: 10.4274/jcrpe.1891

[8] Roženková K., Güemes M., Shah P., Hussain K. The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia // J Clin Res Pediatr Endocrinol. 2015. Vol. 7. No. 2. P. 86–97. DOI: 10.4274/jcrpe.1891

[9] Kapoor RR, Flanagan SE, Arya VB, et al. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol. 2013;168(4):557–564. DOI: 10.1530/EJE-12-0673

[10] Kapoor R.R., Flanagan S.E., Arya V.B., et al. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism // Eur J Endocrinol. 2013. Vol. 168. No. 4. P. 557–564. DOI: 10.1530/EJE-12-0673

[11] Fékété CN, de Lonlay P, Jaubert F, et al. The surgical management of congenital hyperinsulinemic hypoglycemia in infancy. J Pediatr Surg. 2004;39(3):267–269. DOI: 10.1016/j.jpedsurg.2003.11.004

[12] Fékété C.N., de Lonlay P., Jaubert F., et al. The surgical management of congenital hyperinsulinemic hypoglycemia in infancy // J Pediatr Surg. 2004. Vol. 39. No. 3. P. 267–269. DOI: 10.1016/j.jpedsurg.2003.11.004

[13] Ribeiro M-J, Boddaert N, Bellanné-Chantelot C, et al. The added value of [18F] fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging. 2007;34(12):2120–2128. DOI: 10.1007/s00259-007-0498-y

[14] Ribeiro M.-J., Boddaert N., Bellanné-Chantelot C., et al. The added value of [18F] fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children // Eur J Nucl Med Mol Imaging. 2007. Vol. 34. No. 12. P. 2120–2128. DOI: 10.1007/s00259-007-0498-y

[15] Gubaeva DN, Melikyan MA, Ryzhkova DV, et al. Clinical, genetic, and radionuclide characteristics of the focal form of congenital hyperinsulinism. Problems of Endocrinology. 2019;65(5):319–329. (In Russ.) DOI: 10.14341/probl10317

[16] Губаева Д.Н., Меликян М.А., Рыжкова Д.В., и др. Клинические, генетические и радионуклидные характеристики пациентов с фокальной формой врожденного гиперинсулинизма // Проблемы эндокринологии. 2019. Т. 65, № 5. С. 319–329. DOI: 10.14341/probl10317

[17] Graham EA, Hartmann AF. Subtotal resection of the pancreas for hypoglycaemia. Surg Gynecol Obstet. 1934;59:474–479.

[18] Graham E.A., Hartmann A.F. Subtotal resection of the pancreas for hypoglycaemia // Surg Gynecol Obstet. 1934. Vol. 59. P. 474–479.

[19] Miquel G, Cebrian R, Yeste D, et al. Glucose intolerance and diabetes are observed in the long-term follow-up of nonpancreatectomized patients with persistent hyperinsulinemic hypoglycemia of infancy due to mutations in the ABCC8 gene. Diabetes Care. 2008;31(6):1257–1259. DOI:10.2337/dc07-2059

[20] Miquel G., Cebrian R., Yeste D., et al. Glucose intolerance and diabetes are observed in the long-term follow-up of nonpancreatectomized patients with persistent hyperinsulinemic hypoglycemia of infancy due to mutations in the ABCC8 gene // Diabetes Care. 2008. Vol. 31. No. 6. P. 1257–1259. DOI:10.2337/dc07-2059

[21] Han B, Mohamed Z, Estebanez MS, et al. Atypical forms of congenital hyperinsulinism in infancy are associated with mosaic patterns of immature islet cells. J Clin Endocrinol Metab. 2017;102(9):3261–3267. DOI: 10.1210/jc.2017-00158

[22] Han B., Mohamed Z., Estebanez M.S., et al. Atypical forms of congenital hyperinsulinism in infancy are associated with mosaic patterns of immature islet cells // J Clin Endocrinol Metab. 2017. Vol. 102. No. 9. P. 3261–3267. DOI: 10.1210/jc.2017-00158

[23] Kassem SA, Ariel I, Thornton PS, et al. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes. 2000;49(8):1325–1333. DOI: 10.2337/diabetes.49.8.1325

[24] Kassem S.A., Ariel I., Thornton P.S., et al. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy // Diabetes. 2000. Vol. 49. No. 8. P. 1325–1333. DOI: 10.2337/diabetes.49.8.1325

[25] Kapoor RR, Locke J, Colclough K, et al. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes. 2008;57(6):1659–1663. DOI: 10.2337/db07-1657

[26] Kapoor R.R., Locke J., Colclough K., et al. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations // Diabetes. 2008. Vol. 57. No. 6. P. 1659–1663. DOI: 10.2337/db07-1657

[27] Laje P, Stanley CA, Palladino AA, et al. Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism. J Pediatr Surg. 2012;47(1):130–135. DOI: 10.1016/j.jpedsurg.2011.10.032

[28] Laje P., Stanley C.A., Palladino A.A., et al. Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism // J Pediatr Surg. 2012. Vol. 47. No. 1. P. 130–135. DOI: 10.1016/j.jpedsurg.2011.10.032

[29] Mazor-Aronovitch K, Landau H, Gillis D. Surgical versus non-surgical treatment of congenital hyperinsulinism. Pediatr Endocrinol Rev. 2009;6(3):424–430.

[30] Mazor-Aronovitch K., Landau H., Gillis D. Surgical versus non-surgical treatment of congenital hyperinsulinism // Pediatr Endocrinol Rev. 2009. Vol. 6. No. 3. P. 424–430.

[31] Al-Rabeeah A, Al-Ashwal A, Al-Herbish A, et al. Persistent hyperinsulinemic hypoglycemia of infancy: Experience with 28 cases. J Pediatr Surg. 1995;30(8):1119–1121. DOI: 10.1016/0022-3468(95)90001-2

[32] Al-Rabeeah A., Al-Ashwal A., Al-Herbish A., et al. Persistent hyperinsulinemic hypoglycemia of infancy: Experience with 28 cases // J Pediatr Surg. 1995. Vol. 30. No. 8. P. 1119–1121. DOI: 10.1016/0022-3468(95)90001-2

[33] Lord K, Dzata E, Snider KE, et al. Clinical Presentation and Management of Children With Diffuse and Focal Hyperinsulinism: A Review of 223 Cases. J Clin Endocrinol Metab. 2013;98(11):E1786–E1789. DOI: 10.1210/jc.2013-2094

[34] Lord K., Dzata E., Snider K.E., et al. Clinical Presentation and Management of Children With Diffuse and Focal Hyperinsulinism: A Review of 223 Cases // J Clin Endocrinol Metab. 2013. Vol. 98. No. 11. P. E1786–E1789. DOI: 10.1210/jc.2013-2094

[35] Meissner T, Wendel U, Burgard P, et al. Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol. 2003;149(1):43–51. DOI: 10.1530/eje.0.1490043

[36] Meissner T., Wendel U., Burgard P., et al. Long-term follow-up of 114 patients with congenital hyperinsulinism // Eur J Endocrinol. 2003. Vol. 149. No. 1. P. 43–51. DOI: 10.1530/eje.0.1490043

[37] Michelle J, Greer RM, Thomsett MJ, et al. The outcome in Australian children with hyperinsulinism of infancy: early extensive surgery in severe cases lowers risk of diabetes. Clin Endocrinol (Oxf). 2003;58(3):355–364. DOI: 10.1046/j.1365-2265.2003.01725.x

[38] Michelle J., Greer R.M., Thomsett M.J., et al. The outcome in Australian children with hyperinsulinism of infancy: early extensive surgery in severe cases lowers risk of diabetes // Clin Endocrinol (Oxf). 2003. Vol. 58. No. 3. P. 355–364. DOI: 10.1046/j.1365-2265.2003.01725.x

[39] Ni J, Ge J, Zhang M, et al. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning. Eur J Pediatr. 2019;178:1161–1169. DOI: 10.1007/s00431-019-03408-6

[40] Ni J., Ge J., Zhang M., et al. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning // Eur J Pediatr. 2019. Vol. 178. P. 1161–1169. DOI: 10.1007/s00431-019-03408-6

[41] Sukhotskaya AA, Bairov VG, Nikitina IL, et al. Surgical treatment of focal forms of congenital hyperinsulinism: is all clear? Russian Journal of Pediatric Surgery. 2019;23(6):296–302. (In Russ.) DOI: 10.18821/1560-9510-2019-23-6-296-302

[42] Сухоцкая А.А., Баиров В.Г., Никитина И.Л., и др. Хирургическое лечение фокальных форм врожденного гиперинсулинизма: все ли определено? // Детская хирургия. 2019. Т. 23, № 6. С. 296–302. DOI: 10.18821/1560-9510-2019-23-6-296-302

[43] Sukhotskaya AA, Bairov VG, Nikitina IL, et al. Congenital hyperinsulinism in newborns and young children: the state of the problem and the results of surgical treatment. Medical Council. 2021;(11):226–239. (In Russ.) DOI: 10.21518/2079-701X-2021-11-226-239

[44] Сухоцкая А.А., Баиров В.Г., Никитина И.Л., и др. Врожденный гиперинсулинизм у новорожденных и детей раннего возраста: состояние проблемы и результаты хирургического лечения // Медицинский Совет. 2021. № 11. С. 226–239. DOI: 10.21518/2079-701X-2021-11-226-239

[45] Gubaeva DN, Melikyan MA, Ryzhkova DV, Nikitina IL. The use of 18F-DOPA PET/CT imaging in congenital hyperinsulinism. Russian electronic journal of radiology. 2017;7(3):144–152. (In Russ.) DOI: 10.21569/2222-7415-2017-7-3-144-152

[46] Губаева Д.Н., Меликян М.А., Рыжкова Д.В., Никитина И.Л. ПЭТ/КТ с 18F-ДОФА при врожденном гиперинсулинизме // Russian electronic journal of radiology. 2017. Т. 7, № 3. С. 144–152. DOI: 10.21569/2222-7415-2017-7-3-144-152

[47] Sukhotskaya AA, Bairov VG, Mitrofanova LB, et al. Surgical treatment of atipical forms of congenital hyperinsulinism. Russian Journal of Pediatric Surgery. 2020;24(2):83–88. (In Russ.) DOI: 10.18821/1560-9510-2020-24-2-83-88

[48] Сухоцкая А.А., Баиров В.Г., Митрофанова Л.Б., и др. Атипичные формы врожденного гиперинсулинизма: хирургическое лечение // Детская хирургия. 2020. Т. 24, № 2. С. 83–88. DOI 10.18821/1560-9510-2020-24-2-83-88

[49] Hardy OT, Hernandez-Pampaloni M, Saffer JR, et al. Accuracy of (18F) fluoroDOPA positron emission tomography for diagnosis and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab. 2007;92(12):4706–4711. DOI: 10.1210/jc.2007-1637

[50] Hardy O.T., Hernandez-Pampaloni M., Saffer J.R., et al. Accuracy of (18F) fluoroDOPA positron emission tomography for diagnosis and localizing focal congenital hyperinsulinism // J Clin Endocrinol Metab. 2007. Vol. 92. No. 12. P. 4706–4711. DOI: 10.1210/jc.2007-1637

[51] Otonkoski T, Näntö-Salonen K, Seppänen M, et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes. 2006;55(1):13–18. DOI: 10.2337/diabetes.55.01.06.db05-1128

[52] Otonkoski T., Näntö-Salonen K., Seppänen M., et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography // Diabetes. 2006. Vol. 55. No. 1. P. 13–18. DOI: 10.2337/diabetes.55.01.06.db05-1128

[53] Meintjes M, Endozo R, Dickson J, et al. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist’s perspective. Nucl Med Commun. 2013;34(6):601–608. DOI: 10.1097/MNM.0b013e32836069d0

[54] Meintjes M., Endozo R., Dickson J., et al. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist’s perspective // Nucl Med Commun. 2013. Vol. 34. No. 6. P. 601–608. DOI: 10.1097/MNM.0b013e32836069d0

RIGHTS & PERMISSIONS

Sukhotskaya A.A., Bairov V.G., Mitrofanova L.B., Perminova A.A., Rijkova D.V., Nikitina I.L., Amidhonova S.A., Kagantsov I.M.